2nd Annual Forum on Strategic Publication Planning

Develop Enhanced Internal and External Partnerships and Integrated Messaging to Maximize the Value of Your Publication Plan

torcetrapib: “$800 Million” Failure but Kindler Safe

Expect to see Pfizer’s failed attempt to bring torcetrapib to market as an oft-cited object lesson of why the costs of drugs needs to...

5th Annual Pharmaceutical Product Launches

Pre-Launch Market Positioning Strategies for Sales Readiness and Accelerated Product Uptake

2nd Annual Fee-For-Service and Strategic Pharmaceutical Distribution

Maximize the Value of New Trade Agreements, Wholesaler Data and Channel Compliance

Pfizer’s torcetrapib: Who Knew What, When?

Reported today in the Wall Street Journal:"Pfizer Inc. halted development of a drug to boost good cholesterol that was the most important medicine in...

Compliance, Math, and Marketers

I spent the day yesterday at eyeforpharma's 3rd Annual Patient Compliance and Adherence Congress in Philadelphia. I went mainly because I was "commissioned" by...

Pharma Marketing News Vol. 5, #10

Vol. 5, No. 10: December 2006 - EXECUTIVE SUMMARY Welcome to the latest issue of Pharma Marketing News. ...

Betting the Pharm

Pfizer's failure to launch torcetrapib will have repercussions throughout the industry on many different levels.

Teaching New Dogs Old Tricks

An interview with Professor Jim Avery at University of Oklahoma's Gaylord College of Mass Communication about preparing graduate students for a career in health advertising.

Sales Effectiveness Meets eMarketing

Steve Woodruff, Founder and Principal Consultant of Impactiviti, and John Mack team up to review eyeforpharma's Sales Effectiveness conference, which was co-located with the eCommunication & Online Marketing Conference.